<DOC>
	<DOCNO>NCT00442325</DOCNO>
	<brief_summary>European physician tend always use low dose statin initiate therapy even subject require large reduction cholesterol . The study evaluate select start dose base baseline target LDL-C cholesterol would provide good result ( ie proportion subject resching target )</brief_summary>
	<brief_title>Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Vascular Diseases</mesh_term>
	<mesh_term>Stroke</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Atorvastatin Calcium</mesh_term>
	<criteria>High cholesterol blood level ( LDLcholesterol 100 mg/dL 220 mg/dL . Triglycerides 600 mg/dL . History coronary artery disease ( ex . : heart attack , angina ) , stroke , diabetes high risk event . Pregnancy lactation , use high statin dos ( &gt; 40mg ) baseline , liver renal problem Use drug would interfere evaluation efficacy cause safety problem Uncontrolled hypertension , diabetes hypothyroidism Recent cardiac event procedure High baseline CPK level</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2007</verification_date>
</DOC>